SARS-CoV-2 vaccine-induced humoral and cellular immunity in patients with hematologic malignancies

COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches

S Kakavandi, B Hajikhani, P Azizi, F Aziziyan… - Cell Communication and …, 2024 - Springer

Extensive research in countries with high sociodemographic indices (SDIs) to date has
shown that coronavirus disease 2019 (COVID-19) may be directly associated with more …

被引用次数：9 相关文章所有 9 个版本

[PDF] thelancet.com Full View

Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study

Q Hofsink, S Haggenburg, BI Lissenberg-Witte… - …, 2023 - thelancet.com

Background Patients with haematological malignancies have impaired antibody responses
to SARS-CoV-2 vaccination. We aimed to investigate whether a fourth mRNA COVID-19 …

被引用次数：9 相关文章所有 15 个版本

[PDF] mdpi.com

Immune response following BNT162b2 mRNA COVID-19 vaccination in pediatric cancer patients

KLJ Schmidt, NMM Dautzenberg, PM Hoogerbrugge… - Cancers, 2023 - mdpi.com

Simple Summary Children with cancer experience a more severe SARS-CoV-2 infection
and more often die due to COVID-19 than their healthy peers. Vaccination against SARS …

被引用次数：6 相关文章所有 13 个版本

[PDF] nature.com

Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European …

AM Spanjaart, P Ljungman, G Tridello, J Schwartz… - Leukemia, 2024 - nature.com

COVID-19 has been associated with high mortality in patients treated with Chimeric Antigen
Receptor (CAR) T-cell therapy for hematologic malignancies. Here, we investigated whether …

Increase in antibody titer and change over time associated with severe acute respiratory syndrome coronavirus 2 infection after mRNA vaccination: Consideration of …

H Kusunoki, M Ohkusa, R Iida, A Saito… - Clinical Case …, 2024 - Wiley Online Library

Key Clinical Message Most Japanese patients naturally infected with COVID‐19 were
infected after mRNA vaccination, and many maintained high antibody titers due to hybrid …

被引用次数：2 相关文章所有 8 个版本

[PDF] mdpi.com

Initial Efficacy of the COVID-19 mRNA Vaccine Booster and Subsequent Breakthrough Omicron Variant Infection in Patients with B-Cell Non-Hodgkin's Lymphoma: A …

M Saito, A Mori, T Ishio, M Kobayashi, S Tsukamoto… - Viruses, 2024 - mdpi.com

It has been suggested that the effect of coronavirus disease 2019 (COVID-19) booster
vaccination in patients with B-cell non-Hodgkin's lymphoma (B-NHL) is inferior to that in …